AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Apr 19 2023
Many seniors now eligible to get another COVID booster, CDC says
Many seniors can now get another COVID-19 vaccine booster, after the Centers for Disease Control and Prevention greenlighted a broad swath of changes on Wednesday that were first authorized by the Food and Drug Administration the day before. The CDC's move clears the final hurdle for eligible Americans to be able to get another round of the booster shots that were rolled out last year fromCBS News (Online)
May 18 2020
Moderna’s coronavirus vaccine shows encouraging early results in human safety trial
Moderna, the Massachusetts biotechnology company behind a leading effort to create a coronavirus vaccine, announced promising early results from its first human safety tests Monday. The company plans to launch a large clinical trial in July aimed at showing whether the vaccine works.
The company reported that in eight patients who had been followed for a month and a half, the vaccine atWashington Post
Mar 04 2021
Good news about the 'Moderna arm' vaccine rash — it's no worse with second shot
There's good news about "Moderna arm," the raised, sometimes itchy red rash some people get a week or so after being vaccinated with Moderna's COVID-19 vaccine.
There were concerns people who experienced the annoying rash might have a worse reaction with the second dose. A report published Wednesday finds that's not the case – and most don't have any reaction at all the second time.USA TODAY
Feb 17 2021
Lab studies suggest Pfizer, Moderna vaccines can protect against coronavirus variant
A new report published in the New England Journal of Medicine on Wednesday suggests that Pfizer-BioNTech's Covid-19 vaccine can protect people against concerning new coronavirus variants, including one first seen in South Africa called B.1.351.
For the study, researchers at Pfizer and the University of Texas Medical Branch genetically engineered versions of the virus to carry some ofCNN (Online News)
Nov 22 2021
MSNBC's Joy Reid's false 'fact-check' claims Moderna, Pfizer not part of Operation Warp Speed
MSNBC host Joy Reid got her facts wrong when she attempted to fact-check GOP lawmakers who credited Operation Warp Speed for progress in the development of a coronavirus vaccine.
Moderna announced on Monday that interim analysis from a late-stage clinical trial showed its vaccine is 94.5% effective. On Wednesday, Pfizer followed that up with an announcement that its vaccine had beenFox News (Online News)
Oct 14 2021
FDA vaccine advisers recommend emergency use authorization for booster dose of Moderna's Covid-19 vaccine
Vaccine advisers to the US Food and Drug Administration voted unanimously Thursday to recommend emergency use authorization of a booster dose of Moderna's Covid-19 vaccine.
The FDA's Vaccines and Related Biological Products Advisory Committee agreed use of a booster dose would be safe and effective in some people six months out from their primary series.
Moderna had asked forCNN (Online News)
Jul 27 2020
Late-stage clinical trial for Moderna’s COVID-19 vaccine is launched at Brigham and Women’s
A nationwide study begins Monday to find out if a potential coronavirus vaccine, developed by Cambridge-based Moderna and the National Institute of Allergy and Infectious Diseases, is safe and effective in preventing people from getting COVID-19.
The clinical trial will enroll 30,000 people, with Brigham and Women’s Hospital leading the New England section of the trial.
TheThe Boston Globe
Mar 31 2021
U.S. begins testing Moderna’s Covid vaccine booster shots for variant from South Africa
The National Institutes of Health has started testing a new coronavirus vaccine from Moderna designed to protect against a problematic variant first found in South Africa, the agency said Wednesday.
The phase one trial, led and funded by the NIH’s National Institute of Allergy and Infectious Diseases, will test how safe and effective the new shot is against the variant — known as B.1.CNBC
Mar 16 2021
Moderna Gives 1st Vaccine Shots To Young Kids As Part Of COVID-19 Study
Children have now received their first doses of Moderna's COVID-19 vaccine, as the company studies the safety and effectiveness of the vaccine for kids ages 6 months to less than 12 years old.
In the study, researchers will give two injections 28 days apart of either the Moderna vaccine or a saline placebo to children. Kids who get the vaccine will receive one of three possible doses,NPR (Online News)
Feb 23 2022
CDC says waiting longer between Pfizer, Moderna doses may reduce rare myocarditis risk for younger men
The U.S. Centers for Disease Control and Prevention said this week that younger males should consider waiting longer between doses of Pfizer’s and Moderna’s vaccines to reduce a rare risk of heart inflammation.
The CDC said males ages 12- to 39-years-old should consider waiting eight weeks between the first and second doses of their primary Covid vaccination series. Public healthCNBC